ยินดีต้อนรับกลับมา
เข้าร่วม CoinTime
เข้าสู่ระบบ email
สร้างบัญชี email
ตรวจสอบกล่องจดหมายของคุณ
Phenomix
About
Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $55M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2001
- Number Of Employee
- 1 - 10
- Operating Status
- Active
As of October 2010, Phenomix closed down as it was unable to find a partner to pay for is clinical trial bills after Forest Laboratories walked away. Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases. Phenomix' lead clinical candidate, PHX1149, is a DPP4 inhibitor in phase 2 testing as a once daily oral treatment for type 2 diabetes. Phenomix' second program is directed at the treatment of hepatitis C through inhibition of the NS3/4A viral protease. Phenomix is based in San Diego, California.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 8, 2007 | Series C | $55M | 1 |
Phase4 Ventures
|
— | Detail |
| Mar 11, 2002 | Series A | $12M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Phase4 Ventures
|
Yes | Series C |
Versant Ventures
|
— | Series A |
